CCG-203971, CAS [[1443437-74-8]]
Artikelnummer:
MCE-HY-108361
| Artikelname: |
CCG-203971, CAS [[1443437-74-8]] |
| Artikelnummer: |
MCE-HY-108361 |
| Hersteller Artikelnummer: |
HY-108361 |
| Alternativnummer: |
MCE-HY-108361-5MG,MCE-HY-108361-100MG,MCE-HY-108361-25MG,MCE-HY-108361-10MG,MCE-HY-108361-50MG,MCE-HY-108361-10MMX1ML |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC50 =6.4 µM). CCG-203971 inhibits PC-3 cell migration with an IC50 of 4.2 µM. Potential anti-metastasis Agent[1][2]. |
| Molekulargewicht: |
408.88 |
| Reinheit: |
99.89 |
| CAS Nummer: |
[1443437-74-8] |
| Formel: |
C23H21ClN2O3 |
| Target-Kategorie: |
Ras |
| Anwendungsbeschreibung: |
Reference compound |
